ArticleClinical rheumatology2021

On the efficacy and safety of rituximab therapy in patients with systemic sclerosis disease: missing points, bottlenecks, over-exaggeration, and discrepancies-comments on the article by Moradzadeh et al.

Konstantinos Gkiouras et al.PubMed ↗Publisher ↗

No numbers read from the abstract.